Based on the important role of CXCL7 and HASM in the pathogenesis of COPD, IKK inhibitors and other NF-κB inhibitors can provide effective anti-inflammatory effects in patients with COPD. The gene discussed is PPBP; the disease is chronic obstructive pulmonary disease.